MAIA•benzinga•May 15, 2025 at 03:07 PM

MAIA Biotechnology Announces That An Abstract About The Efficacy Data From The Phase 2 THIO-101 Clinical Trial Was Accepted For Poster Presentation At The 2025 Annual Meeting Of The ASCO, Taking Place May 30 To June 3, 2025

No summary available.

Read the full article from the original source for complete details and context.

Article published on May 15, 2025 by benzinga